Christopher Stanley, M.D., MBA, says Henry Ford Health now projects its 2027 employee healthcare insurance premiums to increase half as much as what had been expected, partly because of Populance’s to bring about cost-effective care.
|Articles|June 1, 2001
Lyme disease rising
News brief.
Advertisement
Research Headlines
Lyme disease rising
By Jeanne Sabatie, Production Editor
Whether due to more people getting infected or better reporting of the disease, the incidence of reported Lyme disease has doubled since 1990. In the March 16 Morbidity and Mortality Weekly Report, a summary of cases reported to the CDC in 1999 found that Connecticut, Rhode Island, New York and Pennsylvania had the highest incidence per 100,000 population; children and adults aged 45 to 59 comprised the majority of cases.
Jeanne Sabatie. Lyme disease rising.
Business and Health
2001;6:9.
Advertisement
Related to this article
Rybrevant Faspro won accelerated approval for recurrent or metastatic HNSCC after a trial showed a 42% response rate in previously treated patients.
David Feldshon, M.D., a Yale gastroenterologist who still performs endoscopy two days a week at 75, discusses his approach to MASLD and life outside the clinic.
Researchers in Lyon, France, conducted a retrospective cohort study of intensifying the dosing of biologics such as Humira, adding oral antibiotics, or both as ways to boost the response of patients with hidradenitis suppurativa.
Expect Democrats to flex their oversight powers even if President Donald Trump’s veto power blocks their efforts to reverse Medicaid cuts or restore enhanced ACA subsidies. The administration’s most-favored-nation policies and HHS Secretary Kennedy will probably be in the hot seat.
Health plans should be using data, digital tools and human support to identify potential disruptions early, and whether a member is changing plans or managing a new health condition, the experience should feel guided rather than overwhelming.
Pretax adjusted income from operations from Express Scripts, Cigna's pharmacy benefit manager, fell by 21.5% compared with the third quarter of 2025, while income from operations of its specialty drug business jumped by 15%.
Annesha White, Pharm.D., M.S., Ph.D., and Fredrick Manasseh, Pharm.D., MBA, BCGP, explain where AI helps managed care pharmacy, where bias creeps in and what skills pharmacists need to oversee it.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
WHO adds two Bundibugyo vaccines to Ebola trial in the DRC
2
After a 10-year gap, FDA approves new option for pretreated head and neck cancer
3
Calibrating biologic treatment of HS to the response patterns to biologics
4
Patience and persistence define one Yale gastroenterologist’s approach to MASLD
5